P Mattern

416 total citations
30 papers, 340 citations indexed

About

P Mattern is a scholar working on Epidemiology, Immunology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, P Mattern has authored 30 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 6 papers in Immunology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in P Mattern's work include Trypanosoma species research and implications (13 papers), Immunodeficiency and Autoimmune Disorders (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). P Mattern is often cited by papers focused on Trypanosoma species research and implications (13 papers), Immunodeficiency and Autoimmune Disorders (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). P Mattern collaborates with scholars based in France, Senegal and Germany. P Mattern's co-authors include C. Giroud, T. Baltz, F. Klein, Jacques Blondel, R Camain, George K.B. Sándor, R Masseyeff, C Quénum, Gerhard Mayer and Louis Leblanc and has published in prestigious journals such as Nature, Annals of the Rheumatic Diseases and Experimental Parasitology.

In The Last Decade

P Mattern

21 papers receiving 278 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P Mattern France 8 247 158 96 92 58 30 340
Lain C. Pontes de Carvalho Brazil 11 307 1.2× 223 1.4× 111 1.2× 149 1.6× 42 0.7× 17 437
Linda Logan-Henfrey Kenya 12 228 0.9× 117 0.7× 59 0.6× 24 0.3× 102 1.8× 23 302
Mustapha Chamekh Belgium 7 393 1.6× 297 1.9× 46 0.5× 88 1.0× 151 2.6× 8 520
Florence Ottonès France 10 110 0.4× 87 0.6× 141 1.5× 81 0.9× 34 0.6× 16 333
Catherine Jacquemot France 10 110 0.4× 76 0.5× 110 1.1× 163 1.8× 35 0.6× 11 349
Mike Cross Netherlands 16 457 1.9× 223 1.4× 55 0.6× 344 3.7× 57 1.0× 21 624
M. T. Rimoldi Argentina 10 205 0.8× 160 1.0× 111 1.2× 33 0.4× 50 0.9× 17 325
Erwin Studer Switzerland 9 254 1.0× 154 1.0× 43 0.4× 137 1.5× 12 0.2× 12 336
Edwin C. Rowland United States 12 428 1.7× 289 1.8× 116 1.2× 65 0.7× 102 1.8× 34 481
H. E. Kaufman United States 12 211 0.9× 94 0.6× 59 0.6× 32 0.3× 17 0.3× 25 403

Countries citing papers authored by P Mattern

Since Specialization
Citations

This map shows the geographic impact of P Mattern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Mattern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Mattern more than expected).

Fields of papers citing papers by P Mattern

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Mattern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Mattern. The network helps show where P Mattern may publish in the future.

Co-authorship network of co-authors of P Mattern

This figure shows the co-authorship network connecting the top 25 collaborators of P Mattern. A scholar is included among the top collaborators of P Mattern based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Mattern. P Mattern is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mattern, P, et al.. (1998). [Serological diagnosis of sleeping sickness. II. Complement-fixing antibodies during the infection].. PubMed. 53. 878–85.
2.
Collomb, H, et al.. (1996). [CLINICAL, BIOLOGICAL AND ELECTROENCEPHALOGRAPHIC STUDY OF EXPERIMENTAL TRYPANOSOMIASIS IN ERYTHROCEBUS PATAS].. PubMed. 56. 971–87. 1 indexed citations
3.
Mattern, P, et al.. (1996). Charakterisierung einiger Bacteriocine im Hinblick auf mögliche Anwendungen im Lebensmittelbereich. 1. Mitt. Stammauswahl. Food / Nahrung. 40(4). 212–217. 2 indexed citations
4.
Payet, M, et al.. (1996). [BETA2-MACROGLOBULINEMIA IN THE COURSE OF CERTAIN HEPATOSPLENIC DISEASES OF THE AFRICAN NEGRO (APROPOS OF 100 CASES)].. PubMed. 3. 630–3.
5.
Mattern, P, et al.. (1977). [Effect of magnetic fields and modulated electromagnetic waves on experimental trypanosomiasis].. PubMed. 57(4-5). 501–24.
6.
Mattern, P, et al.. (1977). Trypanosoma equiperdum: Multiplication dans des chambres de diffusion implantées chez la souris. Experimental Parasitology. 43(1). 1–11. 3 indexed citations
7.
Mattern, P, et al.. (1975). [Stimulation of the defenses of trypanosomic mice by a combination of magnetic field and electromagnetic wave radiation].. PubMed. 280(16). 1915–8. 1 indexed citations
8.
Mattern, P, et al.. (1972). [Existence of amastigote forms of Trypanosoma gambiense in the choroidal plexal tissue of experimentally infected mice].. PubMed. 274(10). 1513–5. 3 indexed citations
9.
Blondel, Jacques, et al.. (1972). Low molecular weight IgM in the serum and cerebrospinal fluid of patients infected with Trypanosoma gambiense.. PubMed. 143(3). 291–303. 10 indexed citations
10.
Desmet, G, Abdoul Aziz Wane, & P Mattern. (1970). [Somatic and serum antigens demonstrated during trypanosomiasis due to Trypanosoma gambiense].. PubMed. 164(8). 1879–86. 1 indexed citations
11.
Sándor, George K.B. & P Mattern. (1969). [Study of the serum of Africans presenting various forms of reactional macroglobulinemia].. PubMed. 62(4). 780–9. 1 indexed citations
12.
Masseyeff, R, et al.. (1968). [Value of the study of serum alpha-1-feto-protein in diagnosis of primary cancer of the liver].. PubMed. 13(3). 537–48. 6 indexed citations
13.
Mattern, P, et al.. (1967). [Precipitating antibodies present in the blood and cerebrospinal fluid of patients with human African trypanosomiasis due to T. gambiense].. PubMed. 112(1). 105–12. 1 indexed citations
14.
Klein, F., et al.. (1967). Slowly sedimenting serum components reacting with anti-IgM sera.. PubMed. 13(6). 641–7. 32 indexed citations
15.
Mattern, P, et al.. (1967). Degradation of Human Serum Proteins in the Digestive Tract of Mosquitoes. Nature. 215(5106). 1193–1194.
16.
Mattern, P, G Sándor, & Jean‐Paul Pillot. (1965). [Contribution to the study of immunoglobulins of the cerebrospinal fluid in the course of human neurosyphilis by the technics of immunoelectrophoretic and immunofluorescence analysis].. PubMed. Suppl:120–7. 1 indexed citations
17.
Klein, F. & P Mattern. (1965). rheumatoid factors in primary and reactive macroglobulinaemia.. Annals of the Rheumatic Diseases. 24(5). 458–464. 20 indexed citations
18.
Mattern, P. (1964). [TECHNICS AND EPIDEMIOLOGICAL VALUE OF THE DIAGNOSIS OF HUMAN AFRICAN TRYPANOSOMIASIS BY THE DETERMINATION OF BETA-2-MACROGLOBULIN THE BLOOD AND CEREBROSPINAL FLUID].. PubMed. 107. 415–21. 11 indexed citations
19.
Mattern, P, et al.. (1964). 7 S Globulin, Immunologically Identical to 19 S Gamma-1 (beta-2)-M-globulin, a New Protein of Horse Serum. Nature. 204(4960). 795–796. 21 indexed citations
20.
Mattern, P, et al.. (1961). Immunochemical Studies on the B2-MacroglobuIins in Sera of Patients suffering from Trypanosoma gambiense Infections.. Ann. Inst. Pasteur. 101(3). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026